Amiri, P., Hosseini, S. A., Roshanravan, N., Saghafi-Asl, M., & Tootoonchian, M. (2023). The effects of sodium butyrate supplementation on the expression levels of PGC-1α, PPARα, and UCP-1 genes, serum level of GLP-1, metabolic parameters, and anthropometric indices in obese individuals on weight loss diet: A study protocol for a triple-blind, randomized, placebo-controlled clinical trial. Current controlled trials in cardiovascular medicine, 24(1), 489-8. https://doi.org/10.1186/s13063-022-06891-9
Chicago Style (17th ed.) CitationAmiri, Parichehr, Seyed Ahmad Hosseini, Neda Roshanravan, Maryam Saghafi-Asl, and Mitra Tootoonchian. "The Effects of Sodium Butyrate Supplementation on the Expression Levels of PGC-1α, PPARα, and UCP-1 Genes, Serum Level of GLP-1, Metabolic Parameters, and Anthropometric Indices in Obese Individuals on Weight Loss Diet: A Study Protocol for a Triple-blind, Randomized, Placebo-controlled Clinical Trial." Current Controlled Trials in Cardiovascular Medicine 24, no. 1 (2023): 489-8. https://doi.org/10.1186/s13063-022-06891-9.
MLA (9th ed.) CitationAmiri, Parichehr, et al. "The Effects of Sodium Butyrate Supplementation on the Expression Levels of PGC-1α, PPARα, and UCP-1 Genes, Serum Level of GLP-1, Metabolic Parameters, and Anthropometric Indices in Obese Individuals on Weight Loss Diet: A Study Protocol for a Triple-blind, Randomized, Placebo-controlled Clinical Trial." Current Controlled Trials in Cardiovascular Medicine, vol. 24, no. 1, 2023, pp. 489-8, https://doi.org/10.1186/s13063-022-06891-9.